Study guide
2.3 Parenteral & Injection Dose Calculations
NMC Test of Competence Part 1 CBT — Nursing Field Route Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 Overview of the NMC CBT & Test Structure 1.2 Preparation Strategy & Pearson VUE Exam Rules
2 Chapter 2: Part A — Numeracy & Dosage Calculations
2.1 Metric Units & Conversion Rules in Nursing 2.2 Oral Medication Dosage Calculations 2.3 Parenteral & Injection Dose Calculations 2.4 IV Infusion Rates & Drop-Rate Calculations 2.5 Fluid Balance Charts & Cumulative Intake/Output 2.6 Weight-Based & Paediatric Calculations
3 Chapter 3: Platform 1 — Accountable Professional
3.1 The NMC Code & Professional Accountability 3.2 Informed Consent & The Mental Capacity Act 3.3 Patient Confidentiality, Data Protection & Duty of Candour 3.4 Professional Accountability in Medicines Management 3.5 Professional Boundaries, Ethics & Social Media Use
4 Chapter 4: Platform 2 — Promoting Health & Preventing Ill Health
4.1 Health Promotion, Lifestyle Guidance & Public Health 4.2 Infection Prevention & Control Standards (IPC) 4.3 Immunisation & Public Health Screening Programmes
5 Chapter 5: Platform 3 — Assessing Needs & Planning Care
5.1 Patient Assessment Frameworks & The ABCDE Approach 5.2 NEWS2 Escalation & Clinical Risk Assessment Tools (Waterlow, MUST) 5.3 The Nursing Process (APIE) & SMART Care Planning
6 Chapter 6: Platform 4 — Providing & Evaluating Care
6.1 Safe Administration of Medicines & The 6 Rights 6.2 Aseptic Non-Touch Technique (ANTT) & Wound Management 6.3 Urinary Catheterisation & Invasive Device Care 6.4 Management of the Deteriorating Patient & Emergency Care 6.5 Evaluating Care Outcomes & Modifying Care Plans
7 Chapter 7: Platform 5 — Leading, Managing Care & Teamwork
7.1 Delegation Principles & Supervision of Nursing Care 7.2 Clinical Leadership & Multidisciplinary Teamwork 7.3 Raising Concerns & Whistleblowing Procedures
8 Chapter 8: Platform 6 — Safety, Quality Improvement & Safeguarding
8.1 Incident Reporting, Near Misses & Root Cause Analysis 8.2 Evidence-Based Practice & Clinical Audit 8.3 Safeguarding Vulnerable Adults & Children
9 Chapter 9: Platform 7 & Annexe A — Coordinating Care & Therapeutic Communication
9.1 Continuity of Care, Discharge Planning & Referrals 9.2 Therapeutic Communication & Relationship Building 9.3 Overcoming Communication Barriers & Interpreter Use 9.4 Patient Advocacy & Reasonable Adjustments
10 Chapter 10: Annexe B — Core Nursing Procedures
10.1 Vital Signs Measurement & Physiological Interpretation 10.2 Venepuncture, Peripheral Cannulation & Blood Sampling 10.3 Sharps Safety & Healthcare Waste Management 10.4 Basic Life Support (BLS) & Resuscitation Protocols 10.5 Oxygen Therapy & Airway Management Procedures
2.3 Parenteral & Injection Dose Calculations
Key Takeaways Explain This Topic AI
Parenteral injection volume calculations require strict verification of concentration ratios, where 1:1,000 Adrenaline represents 1 mg/mL and 1:10,000 Adrenaline represents 0.1 mg/mL (100 mcg/mL).
When reconstituting dry powder vials, the powder displacement volume must be included: Final Solution Volume = Volume of Diluent Added + Powder Displacement Volume.
Percentage concentrations (w/v) represent grams per 100 mL; for example, 1% Lidocaine contains 10 mg/mL, whereas 0.9% Sodium Chloride contains 9 mg/mL.
Recommended tissue volume limits are 1.5 mL for subcutaneous injections and 3–5 mL for intramuscular injections in large adult ventrogluteal sites.
Insulin must be administered strictly using dedicated U-100 syringes calibrated in International Units (100 units = 1 mL); standard millilitre syringes are strictly prohibited.
Last updated: July 2026
Parenteral & Injection Dose Calculations in UK Nursing
Parenteral administration refers to drug delivery routes that bypass the gastrointestinal tract, primarily including subcutaneous (SC) , intramuscular (IM) , and intravenous (IV) injections. Because parenteral medications enter systemic circulation rapidly—or instantaneously in the case of IV boluses—erroneous parenteral calculations carry a exceedingly high risk of immediate lethality.
UK registered nurses must master injectable liquid volume calculations, ampoule vs vial preparation, powder reconstitution involving displacement volumes , concentration expressions (ratio strengths and percentages), and specialized unit dosing for high-alert medications such as Insulin and Heparin.
Anatomical Site Volume Limits & Injection Routes
When calculating injection volumes, the calculated result must be evaluated against safe tissue volume capacity limits:
Subcutaneous (SC) Injections: Maximum recommended volume per injection site is 1.5 mL in adults (0.5–1 mL in infants/children). Excess volume causes local tissue necrosis, pain, and poor absorption.
Intramuscular (IM) Injections: Maximum volume per site is 3 mL to 5 mL in large adult muscles (such as the ventrogluteal site), but limited to 2 mL in the deltoid muscle. For infants and thin adults, the maximum IM volume is 1 mL .
Intravenous (IV) Injections: IV boluses or infusions are diluted in larger volumes of compatible fluids (e.g., 50 mL, 100 mL, or 500 mL) administered via volumetric infusion pumps or syringe drivers.
Ampoules, Vials, and Powder Reconstitution
Injectable medications are supplied in two primary physical containers:
Glass or Plastic Ampoules: Self-contained single-dose liquid solutions. Once snapped open, the liquid is drawn up using a filter needle to prevent glass particle contamination.
Vials: Sealed glass containers with a rubber stopper containing either liquid solution or dry powder for reconstitution.
Powder Reconstitution & Displacement Values
Many injectable antibiotics (such as Co-amoxiclav, Ceftriaxone, or Benzylpenicillin) are unstable in liquid form and are supplied as dry powders. Reconstitution involves adding a specific volume of diluent (usually Water for Injections or 0.9% Sodium Chloride) to the powder.
When dry powder dissolves in a liquid diluent, the powder itself occupies physical space. This space is known as the displacement volume (or displacement value). Final Total Solution Volume = Volume of Diluent Added + Powder Displacement Volume \text{Final Total Solution Volume} = \text{Volume of Diluent Added} + \text{Powder Displacement Volume} Final Total Solution Volume = Volume of Diluent Added + Powder Displacement Volume Final Reconstituted Concentration = Total Drug Mass in Vial (mg) Final Total Solution Volume (mL) \text{Final Reconstituted Concentration} = \frac{\text{Total Drug Mass in Vial (mg)}}{\text{Final Total Solution Volume (mL)}} Final Reconstituted Concentration = Final Total Solution Volume (mL) Total Drug Mass in Vial (mg)
Clinical Safety Warning: Ignoring displacement volume results in an incorrect final concentration calculation. For example, if a 1.2 g powder vial displaces 0.8 mL, adding 9.2 mL of diluent yields a total volume of 10 mL (not 9.2 mL). The resulting concentration is 1 , 200 mg / 10 mL = 120 mg/mL 1,200\text{ mg} / 10\text{ mL} = 120\text{ mg/mL} 1 , 200 mg /10 mL = 120 mg/mL .
Concentration Ratios & Percentage Solutions
Parenteral drug strengths are frequently expressed in ratio strengths or weight-in-volume percentage concentrations.
1. Ratio Strengths (e.g., Adrenaline / Epinephrine)
Ratio strengths represent grams of drug per millilitres of solution (g : mL).
1:1,000 Ratio Solution: Means 1 gram of drug in 1,000 mL of solution .
Convert 1 g to mg: 1 , 000 mg / 1 , 000 mL = 1 mg/mL 1,000\text{ mg} / 1,000\text{ mL} = \mathbf{1\text{ mg/mL}} 1 , 000 mg /1 , 000 mL = 1 mg/mL (or 1,000 micrograms/mL).
Used for Intramuscular (IM) injection in Anaphylaxis .
1:10,000 Ratio Solution: Means 1 gram of drug in 10,000 mL of solution .
Convert 1 g to mg: 1 , 000 mg / 10 , 000 mL = 0.1 mg/mL 1,000\text{ mg} / 10,000\text{ mL} = \mathbf{0.1\text{ mg/mL}} 1 , 000 mg /10 , 000 mL = 0.1 mg/mL (or 100 micrograms/mL).
Used for Intravenous (IV) bolus in Cardiac Arrest .
2. Percentage Concentrations (% w/v)
Percentage weight-in-volume (% w/v) represents the number of grams of drug dissolved in 100 mL of solution . Concentration (g/100 mL) = Percentage Value \text{Concentration (g/100 mL)} = \text{Percentage Value} Concentration (g/100 mL) = Percentage Value
1% w/v Solution (e.g., Lidocaine 1%): Contains 1 g per 100 mL = 1 , 000 mg / 100 mL = 10 mg/mL 1\text{ g per } 100\text{ mL} = 1,000\text{ mg} / 100\text{ mL} = \mathbf{10\text{ mg/mL}} 1 g per 100 mL = 1 , 000 mg /100 mL = 10 mg/mL .
2% w/v Solution (e.g., Lidocaine 2%): Contains 2 g per 100 mL = 2 , 000 mg / 100 mL = 20 mg/mL 2\text{ g per } 100\text{ mL} = 2,000\text{ mg} / 100\text{ mL} = \mathbf{20\text{ mg/mL}} 2 g per 100 mL = 2 , 000 mg /100 mL = 20 mg/mL .
0.9% w/v Solution (e.g., 0.9% Sodium Chloride): Contains 0.9 g per 100 mL = 900 mg / 100 mL = 9 mg/mL 0.9\text{ g per } 100\text{ mL} = 900\text{ mg} / 100\text{ mL} = \mathbf{9\text{ mg/mL}} 0.9 g per 100 mL = 900 mg /100 mL = 9 mg/mL .
Specialized Unit Injections: Insulin & Heparin
Certain high-risk biological agents are dosed in International Units (IU or units) rather than metric mass units.
Insulin Dosing
Standard insulin strength in the UK is U-100 , meaning 100 International Units of insulin per 1 mL .
Insulin must only be drawn up using a dedicated U-100 insulin syringe calibrated directly in units.
Standard millilitre syringes or 1 mL IV syringes must never be used for insulin preparation.
Heparin & Low-Molecular-Weight Heparins (LMWH)
Unfractionated Heparin is measured in IU (e.g., 5,000 IU/mL or 25,000 IU/5 mL).
LMWHs (such as Enoxaparin or Tinzaparin) are frequently supplied in pre-filled syringes expressed in IU (e.g., Enoxaparin 4,000 IU in 0.4 mL).
Worked Scenario Examples
:::note Worked Calculation Box 1: IM Ampoule Volume Clinical Scenario: A postoperative adult patient is prescribed 75 mg of Pethidine IM for severe acute pain. The available ampoules contain Pethidine 100 mg in 2 mL. Calculate the volume in mL to administer.
Identify Variables: Prescribed dose D = 75 mg D = 75\text{ mg} D = 75 mg , Stock strength S = 100 mg S = 100\text{ mg} S = 100 mg , Stock volume Q = 2 mL Q = 2\text{ mL} Q = 2 mL .
Apply Formula: Volume = ( 75 mg 100 mg ) × 2 mL \text{Volume} = \left( \frac{75 \text{ mg}}{100 \text{ mg}} \right) \times 2 \text{ mL} Volume = ( 100 mg 75 mg ) × 2 mL
Calculate: 0.75 × 2 = 1.5 mL 0.75 \times 2 = 1.5 \text{ mL} 0.75 × 2 = 1.5 mL .
Clinical Check: 1.5 mL is well within the 3 mL IM limit for the ventrogluteal muscle site.
Final Answer: 1.5 mL :::
:::note Worked Calculation Box 2: Powder Reconstitution with Displacement Clinical Scenario: A prescriber orders 600 mg of IV Co-amoxiclav. The vial contains 1.2 g (1,200 mg) of dry powder with a displacement volume of 0.8 mL. The package insert directs the nurse to add 9.2 mL of Water for Injections. Calculate the volume needed for the 600 mg dose.
Calculate Total Final Solution Volume: Total Volume = 9.2 mL (diluent) + 0.8 mL (displacement) = 10.0 mL \text{Total Volume} = 9.2 \text{ mL (diluent)} + 0.8 \text{ mL (displacement)} = 10.0 \text{ mL} Total Volume = 9.2 mL (diluent) + 0.8 mL (displacement) = 10.0 mL
Determine Final Concentration: 1 , 200 mg in 10 mL 1,200\text{ mg in } 10\text{ mL} 1 , 200 mg in 10 mL .
Apply Formula: D = 600 mg D = 600\text{ mg} D = 600 mg , S = 1 , 200 mg S = 1,200\text{ mg} S = 1 , 200 mg , Q = 10 mL Q = 10\text{ mL} Q = 10 mL . Volume = ( 600 mg 1 , 200 mg ) × 10 mL = 0.5 × 10 = 5.0 mL \text{Volume} = \left( \frac{600 \text{ mg}}{1,200 \text{ mg}} \right) \times 10 \text{ mL} = 0.5 \times 10 = 5.0 \text{ mL} Volume = ( 1 , 200 mg 600 mg ) × 10 mL = 0.5 × 10 = 5.0 mL
Final Answer: 5 mL :::
:::note Worked Calculation Box 3: Adrenaline Ratio Calculation for Anaphylaxis Clinical Scenario: A community nurse responds to an emergency anaphylactic reaction. The protocol specifies 500 micrograms of Adrenaline IM immediately. Stock available: Adrenaline ampoules 1:1,000 (1 mg/mL). Calculate the volume in mL required.
Unit Standardization: Prescribed dose = 500 micrograms. Convert to mg: 500 mcg ÷ 1 , 000 = 0.5 mg 500 \text{ mcg} \div 1,000 = 0.5 \text{ mg} 500 mcg ÷ 1 , 000 = 0.5 mg
Identify Concentration: 1:1,000 Adrenaline = 1 mg/mL = 1\text{ mg/mL} = 1 mg/mL ( S = 1 mg S = 1\text{ mg} S = 1 mg , Q = 1 mL Q = 1\text{ mL} Q = 1 mL ).
Apply Formula: Volume = ( 0.5 mg 1 mg ) × 1 mL = 0.5 mL \text{Volume} = \left( \frac{0.5 \text{ mg}}{1 \text{ mg}} \right) \times 1 \text{ mL} = 0.5 \text{ mL} Volume = ( 1 mg 0.5 mg ) × 1 mL = 0.5 mL
Final Answer: 0.5 mL :::
:::note Worked Calculation Box 4: Heparin Subcutaneous Injection Clinical Scenario: A bedbound surgical patient is prescribed 7,500 IU of Subcutaneous Heparin. Stock vial contains Heparin 10,000 IU/mL. Calculate the injection volume in mL.
Identify Variables: Prescribed dose D = 7 , 500 IU D = 7,500\text{ IU} D = 7 , 500 IU , Stock strength S = 10 , 000 IU S = 10,000\text{ IU} S = 10 , 000 IU , Stock volume Q = 1 mL Q = 1\text{ mL} Q = 1 mL .
Apply Formula: Volume = ( 7 , 500 IU 10 , 000 IU ) × 1 mL = 0.75 mL \text{Volume} = \left( \frac{7,500 \text{ IU}}{10,000 \text{ IU}} \right) \times 1 \text{ mL} = 0.75 \text{ mL} Volume = ( 10 , 000 IU 7 , 500 IU ) × 1 mL = 0.75 mL
Clinical Check: 0.75 mL is within the 1.5 mL subcutaneous volume limit.
Final Answer: 0.75 mL :::